A new study published this week in Future Science OA looks at the quality of responses by ChatGPT to a set of 10 medical questions. Focusing on hematology-oncology, this study provides an opportunity to test performance in a field with rapidly shifting treatment options, often tailored to unique patient profiles.

“When new drugs or research findings emerge, oncologists check in with their colleagues, discuss the implications, and think about how to adapt them to their patients, Chatbots can’t provide that kind of nuance and personalized understanding,” said senior author Justin Taylor, MD , a physician-scientist at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.

However, he still sees a place for the technology. ChatGPT an

See Full Page